Bookmark
Forward
Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding.
Lancet (London, England) 2022 Sep 17Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Maria E de Lange, Judith A F Huirne. Linzagolix: an oral gonadotropin-releasing hormone receptor antagonist treatment for uterine fibroid-associated heavy menstrual bleeding. Lancet (London, England). 2022 Sep 17;400(10356):866-867
Mesh Tags
Substances
PMID: 36116467
View Full Text
